1
|
Celmer M, Opieliński KJ, Dopierała M. Structural model of standard ultrasonic transducer array developed for FEM analysis of mechanical crosstalk. Ultrasonics 2018; 83:114-119. [PMID: 28610713 DOI: 10.1016/j.ultras.2017.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/28/2016] [Revised: 04/18/2017] [Accepted: 06/01/2017] [Indexed: 06/07/2023]
Abstract
One of the reasons of distortions in ultrasonic imaging are crosstalk effects. They can be divided into groups according to the way of their formation. One of them is constituted by mechanical crosstalk, which is propagated by a construction of a multi-element array of piezoelectric transducers. When an individual transducer is excited, mechanical vibrations are transferred to adjacent construction components, thereby stimulating neighboring transducers to an undesired operation. In order to explore ways of the propagation of such vibrations, the authors developed the FEM model of the array of piezoelectric transducers designed for calculations in COMSOL Multiphysics software. Simulations of activating individual transducers and calculated electrical voltages appearing on transducers unstimulated intentionally, were performed in the time domain in order to assess the propagation velocity of different vibration modes through the construction elements. On this basis, conclusions were drawn in terms of the participation of various construction parts of the array of piezoelectric transducers in the process of creating the mechanical crosstalk. The elaborated FEM model allowed also to examine the ways aimed at reducing the transmission of mechanical crosstalk vibrations through the components of the array. Studies showed that correct cuts in the fasteners and the front layer improve the reduction of the mechanical crosstalk effect. The model can become a helpful tool in the process of design and modifications of manufactured ultrasonic arrays particularly in terms of mechanical crosstalk reduction.
Collapse
Affiliation(s)
- M Celmer
- Chair of Acoustics and Multimedia, Faculty of Electronics, Wroclaw University of Science and Technology, Wybrzeze Wyspianskiego 27, 50-370 Wroclaw, Poland.
| | - K J Opieliński
- Chair of Acoustics and Multimedia, Faculty of Electronics, Wroclaw University of Science and Technology, Wybrzeze Wyspianskiego 27, 50-370 Wroclaw, Poland
| | - M Dopierała
- Wroclaw Medical University, Wybrzeze L. Pasteura 1, 50-367 Wroclaw, Poland
| |
Collapse
|
2
|
Rhone P, Ruszkowska-Ciastek B, Celmer M, Brkic A, Bielawski K, Boinska J, Zarychta E, Rosc D. Increased number of endothelial progenitors in peripheral blood as a possible early marker of tumour growth in post-menopausal breast cancer patients. J Physiol Pharmacol 2017; 68:139-148. [PMID: 28456778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Received: 11/29/2016] [Accepted: 02/24/2017] [Indexed: 06/07/2023]
Abstract
The aim of the study was to evaluate the number of circulating endothelial progenitor cells (circulating EPCs) in the blood of patients diagnosed with breast cancer and to make an attempt at finding associations with the number of circulating EPCs and selected clinic-pathological factors; TNM and histological grading, molecular subtype of breast cancer, hormonal status, the expression of Ki-67 and the size of tumour. The study involved 96 Caucasian ethnicity post-menopausal women. Sixty-six women aged 48 - 63 (mean age 55) with breast cancer diagnosis without distant metastases (M0). The median value of the tumour diameter was 1.51 cm. The control group consisted of 30 healthy, non-smoking, post-menopausal women, mean age 49, range 44 - 54 years of age. The exclusion criteria for all the participants were hypertension, hyperlipidaemia, and hyperglycaemia, acute and chronic infection. With regard to the fresh blood samples the number of circulating endothelial progenitors was determined using flow cytometry. The fluorescence of 100,000 cells was measured during the analysis. Circulating EPCs were identified with the immune-phenotype CD45-, CD34+, CD133+, CD31+. A significantly higher number of circulating EPCs in the study group, as compared to the controls (P = 0.0001) and a significantly higher number of circulating EPCs in women over 60 with breast cancer than in the younger women (P = 0.0029) were reported. A positive correlation was noted between circulating EPCs and age as well as between circulating EPCs and HER-2 (P = 0.0231, P = 0.0414, respectively), and a negative correlation between circulating EPCs and histological grading of breast cancer (P = 0.0272). The study has shown a higher number of circulating EPCs in breast cancer patients, which indicates stimulation of neovascularization. Additionally, since bone morrow-derived circulating EPCs are more intensively mobilised in older and overweight breast cancer patients, we can speculate that more aggressive neo-angiogenesis can occur in those patients.
Collapse
Affiliation(s)
- P Rhone
- Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University w Torun, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland.
- Clinical Ward of Breast Cancer and Reconstructive Surgery, Oncology Centre Prof. F. Lukaszczyk Memorial Hospital, Bydgoszcz, Poland
| | - B Ruszkowska-Ciastek
- Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University w Torun, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland
| | - M Celmer
- Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University w Torun, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland
| | - A Brkic
- Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University w Torun, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland
| | - K Bielawski
- Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University w Torun, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland
| | - J Boinska
- Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University w Torun, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland
| | | | - D Rosc
- Department of Pathophysiology, Faculty of Pharmacy, Nicolaus Copernicus University w Torun, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland
| |
Collapse
|